Quadrature Capital’s Transmedics TMDX Stock Holding History

Quadrature Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,499	Closed	-$392K	–	1650
2025 Q3	$392K	Sell	3,499 -5,408	-61%	-$633K	﹤0.01%	599
2025 Q2	$1.19M	Buy	+8,907	New	+$978K	0.02%	382
2024 Q3	–	Sell	-16,750	Closed	-$2.52M	–	1387
2024 Q2	$2.52M	Buy	+16,750	New	+$2.01M	0.04%	276
2023 Q3	–	Sell	-83,502	Closed	-$7.01M	–	1261
2023 Q2	$7.01M	Sell	83,502 -1,718	-2%	-$132K	0.15%	137
2023 Q1	$6.45M	Buy	85,220 +33,086	+63%	+$2.29M	0.18%	128
2022 Q4	$3.22M	Buy	52,134 +32,883	+171%	+$1.75M	0.1%	193
2022 Q3	$803K	Buy	+19,251	New	+$837K	0.03%	418
2022 Q1	–	Sell	-13,420	Closed	-$257K	–	980
2021 Q4	$257K	Buy	13,420 +5,927	+79%	+$149K	0.01%	520
2021 Q3	$248K	Buy	+7,493	New	+$229K	0.01%	557

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Quadrature Capital's TMDX Position: Q4 2025 in Review

Quadrature Capital sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 3,499 shares — an estimated $392K sold.

Quadrature Capital first reported a position in TMDX in Q3 2021 and held it in 9 quarters. The position peaked at $7.01M in Q2 2023. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Quadrature Capital reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Quadrature Capital sold 3,499 Transmedics shares in Q4 2025, an estimated $392K.
Quadrature Capital first reported a position in Transmedics in Q3 2021 and held it in 9 quarters.
Quadrature Capital's Transmedics position peaked at $7.01M in Q2 2023.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.